Bone mass evolution in patients with precocious and advanced puberty treated with LHRH analogs;Evolución de la masa ósea de pacientes con pubertad precoz y pubertad adelantada tratados con análogos de LHRH

Anales Espanoles de Pediatria

Volumn 51, Issue 5, 1999, Pages 499-504

  Ruiz Echarri, M ^a,c   Longás, A Ferrández ^b   Dehesa, E Mayayo ^b  

^a Centro Andrea Prader DGA   (Spain)

^b HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^c Centro Andrea Prader   (Spain)

Author keywords

Advanced puberty; Bone mass; Cortical thickness; Diaphysial diameter; LHRH analogs; Precocious puberty

Indexed keywords

DRUG DERIVATIVE; FERTILITY PROMOTING AGENT; GONADORELIN;

ADOLESCENT; ARTICLE; BONE DEMINERALIZATION; BONE DENSITY; CHILD; FEMALE; HUMAN; MALE; PHYSIOLOGY; PRECOCIOUS PUBERTY;

ADOLESCENT; BONE DEMINERALIZATION, PATHOLOGIC; BONE DENSITY; CHILD; FEMALE; FERTILITY AGENTS, FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MALE; PUBERTY, PRECOCIOUS;

EID: 0033218575     PISSN: 03024342     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Rosen CJ, Kerland ES, Vereault D, y cols. Association between Insulin Growth Factor-I (IGF-I) and a simple sequence repeat in IGF-I gene: implications for genetic studies of bone mineral density. J Clin Endocrinol Metab 1998; 83:2286-2290.
2. Garnero P, Borel O, Grant SF, Ralston SH, Delmas PD. Collagen I alpha 1 Sp1 polimorfism, bone mass and bone turnover in healthy French premenopauseal women: the OFELY study. J Bone Miner Res 1998; 13:813-817.
3. Willing M, Sowes M, Aron D, y cols. Bone mineral density and its change in white women: estrogen and vitamin D receptor genotypes and their interaction. J Bone Miner Res 1998; 13:695-705.
4. Howard G, Nguyen T, Morrison N, y cols. Genetic influences in bone density: physiological correlates of vitamin D receptor gene allelles in premenopauseal women. J Clin Endocrinol Metab 1995; 80:2800-2805.
5. Morrison NA, Qi JC, Tokita A, y cols. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 37:284-287.
6. Schönau E, Werhahn E, Schiedermaier U y cols. Influence of muscle strength on bone strength during childhood and adolescence. Horm Res 1996; 45(Suppl 1):63-66.
7. Matkovic V, Tomislav J, Wardlaw GM y cols. Timing of peak bone mass in Caucasian females and its implication for the prevention of osteoporosis. Inference from a cross-sectional Model. J Clin Invest 1994; 93:799-808.
8. Martin AD, Bayley DA, McKay HA y cols. Bone mineral and calcium accretion during puberty. Am J Clin Nutr 1997; 66:611-615.
9. Mohan S, Baylink D.J. Insulin-like growth factor system components and the coupling of bone formation to resorption. Horm Res 1996; 45(suppl 1):59-62.
10. Mac Gillivray MH, Morishima A, Conte F, Grumbach M, Smith EP. Pediatric endocrinology update: an overview. The essential roles of estrogens in pubertal growth, epiphyseal fusion and bone turnover. Lessons from mutations in the genes for aromatase and the estrogen receptor. Horm Res 1998; 49 Suppl 1:2-8.
11. Carrascosa A, del Río L, Gussinye, Yeste D. Densidad mineral ósea en niños y adolescentes. Patrones de la normalidad. Relación con el crecimiento. An Esp Pediatr 1993; 38 S53:28.
12. Bonjour JP, Theintz G, Buchs B, Slosman D, Rizzoli R. Critical years and stages of puberty for spinal and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 1991; 73:555-563.
13. Dhuper S, Warren MP, Brooks-Gunn J, Fox R. Effects of hormonal status on bone density in adolescent girls. J Clin Endocrinol Metab 1990; 71: 1083-1088.
14. Morishima A, Grumbach MM, Simpson ER, Fisher C, Qin K. Aromatase deficiency in male and female siblings caused by a novel mutation and the physiological role of estrogens. J Clin Endocrinol Metab 1995; 80:3689-3698.
15. Ruiz-Echarri M, Ferrández Longás A, Mayayo E, Labarta JI, Cáncer, E. Evaluation of bone mass on X-rays of the left hand and wrist with a magnifying glass. En: Schönau E, ed. Paediatric Osteology. New Developments in Diagnostics and Therapy. Elsevier Science B.V. 1996; International Congress Series N° 1105:181-190.
16. Barr DGD. Bone deficiency in Turner's Syndrome measured by metacarpals dimensions. Arch Dis Child 1974; 49:821-822.
17. Park E: Cortical bone measurements in Turner's Syndrome. Am J Phys Antrop 1997; 46:455462.
18. Rubin KR. Osteoporosis in Turner Syndrome. En: Rosenfeld RG, Grumbach M, eds. Turner Syndrome. New York: Marcel Decker 1990:301-307.
19. Sagesse G, Bertelloni S, Baroncelli GI. Sex steroids and the acquisition of bone mass. Horm Res 1997; Suppl 5:65-71.
20. Eriksen EF, Colvard DS, Berg NJ, y cols. Evidence of estrogen receptors in normal human osteoblast-like cells. Science 1988; 241: 84-86.
21. Sahito H, Yanaihara T. Steroid formation in osteoblat-like cells. J Int Med Res 1998; 26:1-12.
22. Ferrández A, Rueda C, Ruiz-Echarri M, Mayayo E, Labena C, Puga B. Estudio longitudinal del crecimiento y desarrollo de los niños aragoneses sanos desde el nacimiento. Datos de 0 a 12 años. Gobierno de Aragón. Departamento de Sanidad, Bienestar Social y Trabajo, ed. 1996: 1-22.
23. Theintz G, Buchs B, Rizzoli R y cols. Longitudinal monitoring of bone mass accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine and femoral neck in female subjects. J Clin Endocrinol Metab 1992; 75:1060-1065.
24. Ruiz-Echarri M, Puyuelo P, Villanueva MCy cols. Cortical thickness and metacarpal diameter of normal swiss children from 12 to 20 years old. VIth International Congress of Auxolgy. Madrid 1991: 88.
25. Yturriaga Matarranz R, Roldán Martín B. Adelanto puberal. En: Ferrández Longás A, Pombo Arias M, Rodríguez Hierro F, Yturriaga Matarranz R. Algoritmos diagnóstico terapeúticos en endocrinología pediátrica. Madrid: Semfar 1997: 363.
26. Grumbach MM, Kaplan SL. The neuroendocrinology of human puberty: an ontogenic perspective. En: Grumbach MM, Sizonenko PC, Aubert ML eds. Control of the onset of puberty. Baltimore; Williams and Wilkins 1990; 1-68.
27. a edición. Barcelona: Espaxs 1994: 441.
28. Largo RH, Prader A. Pubertal development in Swiss boys. Pubertal development in Swiss girls. Helv Paediat Acta 1983; 38:211-228 y 229-243.
29. Ferrández A, Rueda C, Labena C, Ruiz-Echarri M. Iatrogenia y pubertad. An Esp Pediatr. Libro de Actas 1996; 80:16-17.
30. Kappy MS, Gannong CS. Advances in the treatment of precocious puberty. Adv Pediatr 1994; 41:223-261.
31. Verroti A, Chiarelli F, Montanaro AF, Morgese G. Bone mineral content in girls with precocious puberty treated with gonadotropin-releasing hormone analog. Gynecol Endocrinol 1995; 9:277-281.
32. Neely EK, Bachrach LK, Hintz RL y cols. Bone mineral density during treatment of central precocious puberty. J Pediatr 1995; 127:819-822.
33. Sagesse G, Bertelloni S, Baroncelli GT, Battini R, Franchi G. Reduction of bone density: an effect of gonadotropin releasing hormone analogue treatment in central precocious puberty. Eur J Pediatr 1993; 152:717-720.
34. Revilla R, Revilla M, Hernández ER, Villa LF, Varela L, Rico H. Evidence that the loss of bone mass induced by GnRH agonists is not totally recovered. Maturitas 1995; 22:145-150.
35. Bonnard GD. Cortical thickness and diaphyseal diameter of the metacarpal bones from the age of three months to eleven years. Helvetica Paediatrica Acta 1968; 5:445-463.
36. Boot AM, Engels MAMJ, Mul D, de Muink Keizer-Schrama SMPF. Bone mineral density in children with central precocious and early puberty (CPP) during treatment with GnRH agonist. Horm Res 1997; 48(suppl 2):18.